Skip to content

Comparison of Wash Wipes and Standard Care in the Prevention of Incontinence-associated Dermatitis in Elderly

A Total Body Wash Wipe Combined With a Genital Wipe Versus Standard Care (Water and pH Neutral Soap) for Washing of Incontinent Residents in a Long- Term Care Setting: a Multicenter Prospective Randomised Controlled Clinical Trial and Health Economical Analysis in Nursing Homes

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02475512
Enrollment
385
Registered
2015-06-18
Start date
2015-05-31
Completion date
2015-12-31
Last updated
2016-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diaper Rash, Incontinence-associated Dermatitis, Irritant Contact Dermatitis Due to Incontinence, Pressure Ulcer

Keywords

elderly, long-term care

Brief summary

Incontinence is a widespread problem in all health care setting. One of the main complications of incontinence is inflammation of the skin in the genital and anal region, also known as incontinence-associated dermatitis (IAD). IAD is a known risk factor of pressure ulcer development. Prevalence figures of IAD vary between 5.6% and 50%. The primary aim of this study is to compare the effectiveness of a 3-in-1 genital wipe versus standard care (traditional water and soap) for the prevention of IAD. The second aim is to perform a health economic evaluation of the 3-in-1 genital wipe versus standard care, and third to compare the cost of a 2-in-1 total body wash wipe versus standard care for total body wash. Other outcomes are the comfort and tolerance of both the nurses and participants. In this Randomized Controlled Trial, performed in 13 long-term care settings, the participants will undergo a 30 day study period. In the experimental intervention, the participants will be washed with body wash wipes and genital wipes. In the control group, the subjects will receive traditional care. IAD as well as Pressure Ulcer prevalence will be monitored. Subjective and objective time measurements will be performed.

Interventions

OTHERWash wipes (3M)
OTHERwater and pH neutral soap

Sponsors

3M
CollaboratorINDUSTRY
University Ghent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* urinary incontinence, fecal incontinence or double incontinence * depending on help for washing * free of skin damage (without signs of pressure ulcers or IAD such as skin breakdown or redness)

Exclusion criteria

* not incontinent or minor incontinent (e.g. stress incontinence) * urinary or fecal catheter * use of incontinence wipes in the uro-genital area two weeks prior to the start of the study * the use of a skin barrier product in the uro-genital area two weeks prior to screening * presence of a bacterial/fungal infection in the uro-genital area

Design outcomes

Primary

MeasureTime frame
Incidence and category of Incontinence-Associated Dermatitiswithin the first 30 days after start of the study

Secondary

MeasureTime frameDescription
Incidence and category of Pressure Ulcerswithin the first 30 days after start of the study
Comfort and tolerance of the participantOn baseline, at day 14 and at day 30 (the end of the study)Questions on comfort and tolerance of the washing method will be assessed by the caregiver. At baseline (day 0) these questions will assess the traditional care. In the middle (day 14) and at the end of the study (day 30) the comfort and tolerance of washing with wash wipes will be assessed in the experimental group. In the control group, comfort and tolerance of traditional care will be assessed three times.
Comfort and preferences of the caregiverOn baseline, at day 14 and at day 30 (the end of the study)Questions on comfort and preferences of the washing method will be assessed. At baseline (day 0) these questions will assess the traditional care. In the middle (day 14) and at the end of the study (day 30) the comfort and preferences of washing with wash wipes will be assessed.
adverse effects of the interventionwithin the first 30 days after start of the studyAdverse effects such as skin irritation, rash, itching, treatment related pain, skin dryness related to the interventions under study will be monitored.
Cost of the experiment (use of wash wipes) versus the standard careFor the duration of the study (30 days)* recording the daily consumption of towels, wash wipes,... * subjective time analyses of the washing methods: Estimated time registration by the caregiver * objective time analyses of the washing methods: time registration using a chronometer, conducted by researcher * retrieval of overhead costs related to traditional hygienic care: washing equipment purchase costs, general water and electricity: given per institution

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026